Skip to content
HeyJared

Springer Health+ IME: Podcast to Practice

Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME.

Podcast · By Springer Health+ IME · English · Official site

Indexed episodes, last 90 days
6
Latest publication
Jul 31, 2026
Audience
Checking…
Earliest in this view
Jul 27, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest episodes

  1. Episode · Jul 31, 2026

    Setting expectations for PC-IOLs | S12E4 (opens the original)

    Episode notes

    Read excerpt

    Dr. Jennifer Loh and Dr. Caroline Watson discuss the importance of patient communication, including managing outcome and financial expectations, in PC-IOL surgery.

  2. Episode · Jul 31, 2026

    Mapping the surgical journey | S12E3 (opens the original)

    Episode notes

    Read excerpt

    Dr. Jennifer Loh and Dr. Caroline Watson explore a stepwise workflow of PC-IOL surgery and formula optimization including individualized calculations and mathematical approaches.

  3. Episode · Jul 31, 2026

    Diagnostics that drive decisions | S12E2 (opens the original)

    Episode notes

    Read excerpt

    Dr. Jennifer Loh and Dr. Rahul Tonk walk through presbyopia-correcting intraocular lens (PC-IOL) preoperative diagnostics and discuss the landscape of PC-IOL technologies.

  4. Episode · Jul 31, 2026

    Presbyopia: Where are we now? | S12E1 (opens the original)

    Episode notes

    Read excerpt

    Dr. Jennifer Loh and Dr. Rahul Tonk provide an overview of presbyopia including the impact on quality of life, economic considerations and current trends in PC-IOLs.

  5. Episode · Jul 27, 2026

    Ensuring equitable access to targeted therapies: the regulatory perspective | S11E2 (opens the original)

    Episode notes

    Read excerpt

    In this video podcast, Dr. Justin Gainor and Dr. Sanjay Popat examine the evolving regulatory and clinical landscape of TRK inhibitors for NTRK fusion–positive NSCLC. They discuss the biology of oncogenic fusions, the evidence supporting current targeted therapies, and the challenges of developing and approving treatments for ultra‑rare molecular subsets. Their conversation highlights global differences in regulatory pathways, barriers to molecular testing, and the need for innovative trial desi

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Not enough subject data for this period yet.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Springer Health+ IME: Podcast to Practice